1.
J Samuelsson, M Mutschler, G Birgegard, P Gram-Hansen, M Bjorkholm, HL Pahl. Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia. Haematologica 2006;91(9):1281-1282; https://doi.org/10.3324/%x.